Danaher Co. (NYSE:DHR) Shares Sold by K.J. Harrison & Partners Inc

K.J. Harrison & Partners Inc trimmed its stake in Danaher Co. (NYSE:DHR) by 47.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,765 shares of the conglomerate’s stock after selling 6,030 shares during the quarter. K.J. Harrison & Partners Inc’s holdings in Danaher were worth $1,555,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of DHR. Kentucky Retirement Systems Insurance Trust Fund increased its stake in Danaher by 11.6% in the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock worth $4,874,000 after purchasing an additional 2,202 shares in the last quarter. Fort Pitt Capital Group LLC boosted its holdings in shares of Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after buying an additional 7,421 shares during the period. ORG Partners LLC increased its position in shares of Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after acquiring an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. raised its holdings in shares of Danaher by 1.2% during the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after acquiring an additional 2,465 shares during the period. Finally, Generate Investment Management Ltd purchased a new stake in shares of Danaher in the 4th quarter valued at approximately $8,044,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on DHR. Scotiabank started coverage on shares of Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective on the stock. Barclays lowered their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. JPMorgan Chase & Co. reduced their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Finally, Wells Fargo & Company reduced their price target on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 11.10% of the stock is owned by corporate insiders.

Danaher Trading Down 0.5 %

Shares of NYSE:DHR opened at $209.27 on Thursday. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The firm has a fifty day moving average price of $225.41 and a 200 day moving average price of $245.78. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $149.57 billion, a PE ratio of 39.63, a P/E/G ratio of 2.66 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the firm posted $2.09 earnings per share. Analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.32 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.